We are live on
!
Find out more
LS
Livforsakringsbolaget Skandia Portfolio holdings
AUM
$2.58B
1-Year Est. Return
30.64%
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
+30.64%
3 Year Est. Return
+115.62%
5 Year Est. Return
+153.42%
10 Year Est. Return
+554.99%
AUM
$139M
AUM Growth
–
Cap. Flow
+$138M
Cap. Flow
% of AUM
99.14%
Top 10 Holdings %
Top 10 Hldgs %
25.56%
Holding
175
New
175
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$6.99M |
| 2 |
IBM
IBM
|
+$4.53M |
| 3 |
Chevron
CVX
|
+$3.99M |
| 4 |
Walmart Inc
WMT
|
+$3.44M |
| 5 |
Johnson & Johnson
JNJ
|
+$3.15M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.73% |
| 2 | Technology | 17.61% |
| 3 | Financials | 15.71% |
| 4 | Energy | 13.72% |
| 5 | Consumer Staples | 10.64% |
Similar funds
GFA
AAS
DCM
PCM
HWA
GAG
ECP
RCMF
Livforsakringsbolaget Skandia's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Livforsakringsbolaget Skandia, which disclosed 175 positions worth $139M. Its ten largest holdings account for 26% of the portfolio.
Its largest position is Pfizer: 253,064 shares worth $6.72M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, followed by Technology and Financials.
- Livforsakringsbolaget Skandia's largest Q2 2013 buy was Pfizer: 253,064 shares worth $6.72M.
- Livforsakringsbolaget Skandia's ten largest holdings make up 26% of its $139M portfolio in Q2 2013.
- Livforsakringsbolaget Skandia disclosed 175 positions in Q2 2013, its first 13F filing on record.
Based on Livforsakringsbolaget Skandia's 13F filing for Q2 2013, filed 2 Jul 2013.